Author

L. Germain

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Lashgari· 1 shared A.-C. Gingras· 1 shared B. Gonzalez-Badillo· 1 shared C. R. Goding· 1 shared E. Audet-Walsh· 1 shared F. J. M. Chartier· 1 shared J. D. R. Knight· 1 shared J. Loehr· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Lashgari

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Systematic profiling of the acetyl lysine machinery reveals a role for MAPKAPK2 in bromodomain inhibitor resistance

P.-E. Kougnassoukou Tchara, J. Loehr, L. Germain, Z. Steinhart, B. Gonzalez-Badillo, A. Lashgari, F. J. M. Chartier, M. Tucholska, S. Picaud, J. D. R. Knight, S. Angers, N. Bisson, C. R. Goding, E. Audet-Walsh, P. Filippakopoulos, , J.-P. Lambert

This study maps the acetyl lysine machinery interactions and identifies MAPKAPK2 as a factor contributing to resistance to BET bromodomain inhibitors in melanoma.

bioRxiv · Jul 22, 2024 · PreprintCancer Biology